التفاصيل البيبلوغرافية
| العنوان: |
Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors. |
| المؤلفون: |
Chen, Monica F., Yang, Soo-Ryum, Shia, Jinru, Girshman, Jeffrey, Punn, Sippy, Wilhelm, Clare, Kris, Mark G., Cocco, Emiliano, Drilon, Alexander, Raj, Nitya |
| المصدر: |
JCO Precision Oncology; 6/30/2023, p1-6, 6p |
| مصطلحات موضوعية: |
PREVENTIVE medicine |
| مستخلص: |
Case report describing response to repotrectinib after development of NTRK resistance mutations that highlights potential utility of sequential TRK inhibitor therapy to prolong disease control [ABSTRACT FROM AUTHOR] |
|
Copyright of JCO Precision Oncology is the property of American Society of Clinical Oncology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
